Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 26 , ISSUE 1 ( January, 2022 ) > List of Articles

LETTER TO THE EDITOR

Medium-chain Triglyceride Ketogenic Diet as a Treatment Strategy for Adult Super-refractory Status Epilepticus

Kaustuv Dutta, Parthasarathy Satishchandra, Monjuri Borkotokey

Keywords : Classic ketogenic diet, Hypoxic-ischemic brain injury, Medium-chain triglyceride ketogenic diet, Refractory status epilepticus, Super-refractory status epilepticus

Citation Information : Dutta K, Satishchandra P, Borkotokey M. Medium-chain Triglyceride Ketogenic Diet as a Treatment Strategy for Adult Super-refractory Status Epilepticus. Indian J Crit Care Med 2022; 26 (1):139-140.

DOI: 10.5005/jp-journals-10071-24073

License: CC BY-NC 4.0

Published Online: 17-01-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

HTML PDF Share
  1. Shorvon S, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012;135(8):2314–2328. DOI: 10.1093/brain/aws091.
  2. Thakur K, Probasco J, Hocker S, Roehl K, Henry B, Kossoff E, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014;82(8):665–670. DOI: 10.1212/WNL.000000 0000000151.
  3. Prasoppokakorn T, Jirasakuldej S, Lakananurak N. Medium-chain triglyceride ketogenic diet is effective for treatment of an adult with super-refractory status epilepticus: a case report and literature review. Eur J Clin Nutr 2019;73(12):1594–1597. DOI: 10.1038/s41430-019-0471-4.
  4. Liu Y, Wang H. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed J 2013;36(1):9. DOI: 10.4103/2319-4170.107154.
  5. Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, et al. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol 2018;17(1):84–93. DOI: 10.1016/S1474-4422(17)30408-8.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.